Baxter International (BAX) Cash from Financing Activities (2009 - 2026)
Baxter International (BAX) posted quarterly Cash from Financing Activities of -$31.0 million for Q2 2026, up 95.93% year-over-year from -$15.8 million in Q2 2025, and down 181.82% quarter-over-quarter from -$11.0 million in Q1 2026.
Baxter International (BAX) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Cash from Financing Activities for 18 consecutive years, with -$31.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities rose 95.93% year-over-year to -$31.0 million; the TTM figure through Jun 2026 stood at -$270.0 million (up 93.24% YoY), while the FY2025 annual figure was -$4.2 billion, down 290.01% from the prior year.
- Cash from Financing Activities fell to -$31.0 million in Q2 2026 per BAX's latest filing, from -$11.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $141.0 million in Q4 2024 and bottomed at -$3.2 billion in Q1 2025.
- Historically, Cash from Financing Activities has averaged -$570.3 million across 5 years, with a median of -$146.5 million in 2024.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 2366.39% — and 2024, when it surged 104.8%.
- Baxter International's Cash from Financing Activities stood at -$119.0 million in 2022, then sank by 2366.39% to -$2.9 billion in 2023, then soared by 104.8% to $141.0 million in 2024, then plunged by 204.26% to -$147.0 million in 2025, then jumped by 78.91% to -$31.0 million in 2026.
- Business Quant data shows BAX's Cash from Financing Activities at -$31.0 million in Q2 2026, -$11.0 million in Q1 2026, and -$147.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -67.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.00 Mn |
| Jun 30, 2026 | -31.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Sep 30, 2025 | -81.00 Mn |
| Sep 30, 2025 | -81.00 Mn |
| Jun 30, 2025 | -762.00 Mn |
| Jun 30, 2025 | -762.00 Mn |
| Mar 31, 2025 | -3.23 Bn |
| Mar 31, 2025 | -3.23 Bn |
| Dec 31, 2024 | 141.00 Mn |
| Dec 31, 2024 | 141.00 Mn |
| Sep 30, 2024 | -146.00 Mn |
| Sep 30, 2024 | -146.00 Mn |
| Jun 30, 2024 | -936.00 Mn |
| Jun 30, 2024 | -936.00 Mn |
| Mar 31, 2024 | -140.00 Mn |
| Mar 31, 2024 | -140.00 Mn |